UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,863,748 | +94.3% | 275,785 | +43.5% | 0.00% | +100.0% |
Q2 2023 | $1,988,525 | +60562.8% | 192,128 | -45.8% | 0.00% | -50.0% |
Q1 2023 | $3,278 | +33.3% | 354,776 | +28.0% | 0.00% | +100.0% |
Q4 2022 | $2,459 | -99.9% | 277,248 | -36.9% | 0.00% | -50.0% |
Q3 2022 | $3,657,000 | -27.5% | 439,522 | -28.7% | 0.00% | -33.3% |
Q2 2022 | $5,047,000 | +269.2% | 616,245 | +292.8% | 0.00% | +200.0% |
Q1 2022 | $1,367,000 | +112.9% | 156,904 | +132.5% | 0.00% | – |
Q4 2021 | $642,000 | -44.4% | 67,492 | -1.7% | 0.00% | -100.0% |
Q3 2021 | $1,155,000 | +18.6% | 68,687 | +7.7% | 0.00% | 0.0% |
Q2 2021 | $974,000 | -32.6% | 63,800 | -14.0% | 0.00% | 0.0% |
Q1 2021 | $1,445,000 | +12.1% | 74,201 | +3.7% | 0.00% | 0.0% |
Q4 2020 | $1,289,000 | -25.5% | 71,522 | -20.3% | 0.00% | -50.0% |
Q3 2020 | $1,730,000 | -37.7% | 89,708 | -15.6% | 0.00% | -50.0% |
Q2 2020 | $2,776,000 | +976.0% | 106,279 | +879.1% | 0.00% | – |
Q3 2019 | $258,000 | -92.1% | 10,855 | -88.0% | 0.00% | -100.0% |
Q2 2019 | $3,248,000 | -12.0% | 90,368 | -9.5% | 0.01% | -16.7% |
Q1 2019 | $3,690,000 | -22.0% | 99,894 | -9.1% | 0.01% | -14.3% |
Q4 2018 | $4,732,000 | -57.1% | 109,892 | -52.9% | 0.01% | -50.0% |
Q3 2018 | $11,021,000 | +28.5% | 233,353 | +35.4% | 0.01% | +27.3% |
Q2 2018 | $8,575,000 | +8.5% | 172,332 | +8.3% | 0.01% | 0.0% |
Q1 2018 | $7,906,000 | +1751.5% | 159,113 | +1285.4% | 0.01% | +1000.0% |
Q4 2017 | $427,000 | – | 11,485 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |